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 Introduction
 Defensins are antimicrobial peptides secreted by vari-
ous cells as a component of the innate host defense  [1, 2] . 
Their bactericidal activity lies in their ability to form mi-
cropores in the phospholipid bilayer of bacterial mem-
branes, causing a loss of structural integrity and collapse 
of the bacterial cell  [3, 4] . Chemotactic activity has been 
attributed to different defensins. Human   -defensins 1–4 
(DEFA1–4) act chemotactically upon monocytes, naive T 
cells and immature dendritic cells  [5] . Human   -defen-
sins 1 and 2 recruit memory T cells and immature den-
dritic cells via binding to the chemokine-receptor CCR6 
 [6] . Through these mechanisms, defensins may not only 
act as a local antimicrobial defense, but may also link the 
innate and acquired immune system in their protective 
response. In addition,   -defensins appear to be impor-
tant antiinflammatory signal peptides regulating poten-
tially tissue-destructive responses  [7] .
 During renal replacement therapy by peritoneal di-
alysis (PD), bacterial peritonitis is a rare complication 
with an incidence of 1.1% per patient per year  [8] , despite 
the permanent peritoneal exposition to the dialysis solu-
tion and the catheter. Even in cases of a severe intestinal 
mucositis with loss of the normal intestinal epithelial 
barrier, a spontaneous peritonitis is a rare complication. 
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 Abstract
 Background: Spontaneous peritonitis is a rather rare event, 
even in peritoneal dialysis (PD). As defensins are natural an-
timicrobial peptides, we hypothesized that adipocytes as 
the major constituents of the omentum could play an impor-
tant role in protecting against infection by generating de-
fensin (DEFA1–3).  Methods: We isolated adipocytes from the 
omentum majus and conducted qualitative and quantitative 
RT-PCR and immunohistochemical analyses.  Results: For the 
first time described, we were able to detect DEFA1–3 mRNA 
in highly purified isolated omental adipocytes. The expres-
sion of DEFA1–3 in adipocytes was confirmed on the protein 
level by immunohistochemistry.  Conclusion: Our report of 
DEFA1–3 expression by human omental adipocytes adds to 
the role of adipocytes in the primary defense against bacte-
rial infection. This may include PD, where the presence of the 
catheter as a foreign body and the nonphysiological dialysis 
solution may require constant defense measures to prevent 
peritonitis, a hypothesis that will require further testing.
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Because of this relative resistance of the peritoneal cavity 
to infection, we hypothesized that adipocytes as the ma-
jor constituents of the omentum could play an important 
role in protecting against peritonitis. We therefore ex-
amined the potential of omental adipocytes to generate 
defensin.
 Material and Methods
 Human Tissue
 Under protocols approved by the local ethics committee, peri-
toneal tissue (omentum majus) was obtained from patients under-
going abdominal surgery. The anonymous samples were immedi-
ately snap frozen in liquid nitrogen and stored at –80   °   C. Periph-
eral blood leukocytes were obtained from healthy adult volunteers 
by venipuncture and served as controls for DEFA1–3.
 Isolation of Adipocytes
 The adipose tissue was placed in DME medium (Life Tech-
nologies), 1 ml medium for each gram tissue, and 1 mg of colla-
genase (Type 1, No. C1–22 Biochrom) and 15 mg of bovine serum 
albumin/ml medium. The procedure of adipocyte isolation was 
carried out under sterile conditions according to a modified 
method described by Rodbell  [9] . The cell suspension containing 
adipocytes was filtrated through a 30-  m mesh in order to elim-
inate contaminating endothelial cells. Next, 3 centrifugation 
steps (400  g for 1 min), leading to the pelleting of all other cell 
types with the exception of adipocytes, and 3 intermittent wash-
ing steps were carried out. Furthermore, the overnight seeding of 
the cell suspension in our stimulation experiments led to a further 
‘purification’ of adipocytes, as all other cell types, including gran-
ulocytes, adhered to the cell culture wells, while adipocytes re-
mained floating. Thus, by microscopic inspection the isolated 
adipocytes used were essentially free of other contaminating cell 
types, including granulocytes.
 Stimulation Experiments
 Isolated adipocytes were disseminated in 6- or 12-well plates 
in DME medium (+10% FCS, heat-inactivated) and were then ei-
ther left unstimulated or were stimulated with tumor necrosis fac-
tor (TNF)-  (20 ng/ml; R&D Systems, Minneapolis, Minn., USA), 
interferon (IFN)-  (40 ng/ml; Sigma Chemical, St. Louis, Mo., 
USA), lipopolysaccharide (LPS; R595 from  Salmonella minnesota , 
Sigma, in RPMI-1640; end concentration 1   g/ml) or heat-inacti-
vated bacteria (100   °   C for 30 min) [ Staphylococcus aureus Ameri-
can Type Culture Collection (ATCC) 29213, 10 10  CFU/ml;  S. au-
reus ATCC 25923, 10 10  CFU/ml;  Pseudomonas aeruginosa ATCC 
27583, 10 9  CFU/ml;  Escherichia  coli  ATCC 25922, 10 9  CFU/ml]. 
Unless stated otherwise, the exposure time was 20 h.
 RNA Isolation
 This was performed according to the method by Chomczyn-
ski and Sacchi  [10] . The quality of a RNA preparation was evalu-
ated by separation on a 1% agarose gel in 1 ! morpholinopropane-
sulfonic acid buffer. 
 RT-PCR for Human DEFA1–3
 Total RNA (1–2   g) was reverse transcribed with SuperScript 
reverse transcriptase (200 U/  l; Gibco) using oligo dTs. Specific 
primers (Invitrogen, Karlsruhe, Germany) for DEFA1–3 were: 5  -
TCCCCAGAAGTGGTTGTTTCC-3  and 5  -GCAGAATGCCC-
AGAGTCTTC-3  , generating a 161-bp product. The PCR condi-
tions for DEFA1–3 were denaturation for 75 s at 95   °   C, annealing 
for 60 s at 57   °   C, and extension for 30 s at 72   °   C for a total of 40 
cycles. The PCR was performed in the ‘Robo Cycler Gradient 96 
Stratagene’. For each of the probes, a   -actin control was run in 
parallel (361 bp).
 Sequencing of the DNA
 The PCR product was isolated using the QiaQuick Gel Extrac-
tion Kit (Qiagen) before sequencing. The nucleotide sequence was 
blasted with the standard NCBI nucleotide-nucleotide blast pro-
gram (www.ncbi.nlm.nih.gov/blast). The detection was carried 
out by MediGenomix (Martinsried, Germany; sequenzing   @   me-
digenomix.de).
 TaqMan PCR
 The TaqMan PCR was carried out in the TaqMan ABI 7700 
Sequence Detection System (PE Biosystems, Weiterstadt, Germa-
ny). Each 20   l reaction consisted of 2   l cDNA, 10   l 2 ! PCR 
master mix (Applied Biosystems No. 4318157), 1   l of the forward 
and reverse primer, and the assay by design TaqMan probe 
(DEFA1–3), as well as 7   l ddH 2 O. The TaqMan conditions for 
DEFA1–3 were 2 min at 50   °   C followed by 10 min at 95   °   C, then 40 
cycles at 95   °   C for 15 s and 60   °   C for 60 s. The sequences of the 
primers and the probe used were as following: forward: CCTTG-
CATGGGACGAAAGCT; reverse: GCACGCTGGTATTCTG-
CAAT; fluorescence probe: FAM-CTTGAGCCTGGATGCTTT. 
Glyceraldehyde-3-phosphate dehydrogenase and ribosomal RNA 
served as house keeping genes (Applied Biosystems). Genomic 
contamination was excluded as all samples had been DNAse 
treated and RT controls were negative.
 Immunohistochemistry
 Immunohistochemical analyses were carried out on 5-  m 
frozen tissue sections of the omentum majus using the alkaline 
phosphatase/antialkaline phosphatase method. Frozen sections 
were incubated for 2 h at room temperature with a monoclonal 
mouse anti-human DEFA1–3 antibody (1:  2,000; BMA, Basel, 
Switzerland). The incubation with the secondary antibody took 
place at room temperature for 30 min. The secondary antibody 
was a rabbit anti-mouse antibody (Z259, dilution 1:  40; DAKO). 
Then, a further incubation with an alkaline phosphatase-specific 
monoclonal mouse antibody (D651, dilution 1:  40; DAKO) was 
carried through for 1 h at room temperature. All dilutions were 
carried out in phosphate-buffered saline (pH 7.6). For staining, 
sections were exposed for 15 min to a solution of sodium nitrite 
(28 m M ), new fuchsin (basic fuchsin 21 m M ), naphthol-AS-B1-
phosphate (0.5  M ), dimethylformamide (64 m M ), and levamisole 
(5 m M ) in 50 m M Tris-HCl buffer (pH 8.4) containing 164 m M 
NaCl. The specificity of the DEFA1–3 staining was confirmed by 
preabsorption with the synthetic DEFA1–3 peptide (0.5   g/  l; 
Bachem, Germany).
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 Results
 RT-PCR for DEFA1–3
 The adipocytes isolated from whole omentum and 
used in subsequent experiments were highly purified. 
The second filtration step through the 30-  m mesh dur-
ing the isolation procedure (see Material and Methods) 
eliminates contaminating endothelial cells. The high de-
gree of purity was further achieved by including 3 cen-
trifugation steps followed by 3 washing steps in the isola-
tion procedure. These centrifugation steps led to pellet-
ing of all other cell types, with the exception of adipocytes, 
which float to the surface. Stromal-vascular cells (capil-
lary, endothelial, mast, macrophage and epithelial cells) 
were absent from the adipocyte preparation upon histo-
logical examination.
 By RT-PCR, a band of the appropriate size for DEFA1–
3 (161 bp) was observed in granulocytes (positive control) 
and adipocytes. These results were consistently repro-
ducible (n = 10) with adipocyte preparations from differ-
ent donors (n = 5). In the next step, we stimulated adipo-
cytes with 20 ng TNF-  /ml + 40 ng IFN-  /ml of DME 
culture medium containing 1% FCS and examined the 
inducibility of defensin expression. Both unstimulated 
and stimulated adipocytes revealed specific expression 
( fig. 1 ). The PCR product was sequenced and found to be 
homologous with the published DEFA1–3 gene sequence. 
 Quantitative RT-PCR for DEFA1–3
 Using quantitative TaqMan PCR, we examined adipo-
cyte cDNA after separate stimulation with TNF-  , IFN-
  , LPS, or heat-inactivated bacteria (including  E. coli ,  P. 
aeruginosa , and two  S. aureus  strains). None of these con-
ditions resulted in a significant alteration of the mRNA 
for DEFA1–3 (data not shown).
 Immunohistochemistry for DEFA1–3
 We next performed immunohistochemistry on tissue 
sections from omentum majus (n = 5). DEFA1–3 staining 
could be attributed to adipocytes, as shown in  figure 2 a, 
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2 3 4 5 6 7 8 9 10 Fig. 1. RT-PCR for DEFA1–3. 1 = Marker;
2 = positive control (granulocytes) RT+;
3 = adipocytes unstimulated RT+; 5 = adi-
pocytes stimulated with cytokines RT+; 3, 
7, 9 = unstimulated adipocytes from dif-
ferent preparations RT+; 4, 6, 8, 10 = adi-
pocytes RT–. 
 Fig. 2. Immunohistochemistry for DEFA1–
3.  a ,  b Omental tissue stained with DEFA1–
3 monoclonal antibody showed a strong 
positive signal for the adipocyte cytoplasm 
and the infiltrating leukocytes ( p ).  c Neg-
ative control with omission of the first an-
tibody.  d Disappearance of the positive 
signal for DEFA1–3 in the omentum and 
the leukocytes after absorption of the an-
tibody with the synthetic DEFA1–3 anti-
gen. 
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excluding endothelial cells of capillaries in the omentum 
majus as potential sources. It should be noted that omen-
tal leukocytes were also strongly positive for DEFA1–3, as 
shown in  figure 2 b, but that the staining of omental adi-
pocytes was independent of any surrounding leukocytes. 
The negative control (omission of the primary antibody) 
is shown in  figure 2 c. The specificity of the DEFA1–3 
staining was also confirmed by preabsorption with the 
synthetic DEFA1–3 peptide, which served as the antigen 
in the DEFA1–3 antibody generation. This resulted in the 
complete disappearance of the adipocyte and leukocyte 
staining, thus confirming the specificity of the signal as 
shown in  figure 2 d.
 Discussion
 While multiple tissues, including the peritoneum of 
patients on PD  [11, 12] , have been examined for their de-
fensin expression, we are not aware of defensin detection 
in adipose tissue and isolated adipocytes. Based on the 
isolation procedure also used in other publications, we 
consider our isolated adipocytes to be highly purified. We 
therefore believe that our data support the presence of 
DEFA1–3 in adipocytes. We were able to show the mRNA 
expression for DEFA1–3 in highly purified isolated omen-
tal adipocytes from different donors. The expression of 
DEFA1–3 was not inducible by TNF-  or IFN-  , LPS or 
exposure to bacteria. The expression of DEFA1–3 in peri-
toneal adipocytes was also confirmed on the protein lev-
el by immunohistochemistry, adding fat cells and spe-
cifically omentum to the tissues capable of generating de-
fensin.
 At this point, we can only speculate about the concen-
trations of defensins produced by omental adipocytes. 
Hypothetically, adipocytes could play a reinforcing role 
in the context of well-studied and established immune 
response pathways through the production of defensins. 
Interestingly, we found DEFA1–3 production not only in 
omental adipocytes, but also in subcutaneous adipose tis-
sue (data not shown). Thus, a constitutive production of 
DEFA1–3 by adipocytes in the subcutaneous and omental 
fat may represent an additional defense against the exter-
nal environment in the skin as well as in the peritoneal 
cavity. It is the ubiquitous occurrence of adipocytes that 
turns them into a pool of antimicrobial peptide produc-
tion.
 We could not stimulate expression of DEFA1–3 in 
omental adipocytes. Potentially during infection gener-
ated DEFA1–3 constitutively would be released, similar to 
the constitutive expression of the human   -defensin 1 
(hBD-1) in epithelia, that is then released upon inflam-
matory signals  [13, 14] .
 Unfortunately, we could not get a usable protein ex-
tract from the adipocytes for Western blot analysis due to 
interference from the very high fat content. Various 
methods to get around this still resulted in a protein 
smear on the gel. Finally, we therefore took recourse to 
the immunohistochemistry method, which has the ad-
ditional advantage of localizing DEFA1–3 to specific cell 
types.
 Our observations add to the reports that postulate a 
novel function of adipose tissue in immunity. For over 40 
years, it is known that the omentum plays a role in host 
defense, as it is a place of antibody synthesis  [15] . Over 
several decades, omental transposition has been success-
fully applied to reduce infection and accelerate the 
wound-healing process [e.g.  16, 17 ]. Adipose tissue can 
produce adipokines that include potent proinflammato-
ry mediators  [18] . The fundamental importance of the 
interplay between immunological tissue (lymphomyeloid 
cells) and adipose tissue has recently emerged in concepts 
about the inflammatory basis of the metabolic syndrome 
 [19, 20] . Our report of DEFA1–3 expression by human 
omental adipocytes adds to the role of adipocytes in pri-
mary defense against bacterial infection. The finding of 
the adipocyte as a site of defensin production is of inter-
est, as adipocytes are ubiquitous in the human body. The 
release of DEFA1–3 constitutively synthesized by and 
stored in omental adipocytes could contribute to local 
microbicidal effects and chemotactic properties as pro-
tective mechanisms in the peritoneum. This may include 
PD, where the presence of the catheter as a foreign body 
and the nonphysiological dialysis solution may require 
constant defense measures to prevent peritonitis, a hy-
pothesis that will require further testing. While our re-
sults provide initial evidence for DEFA1–3 generation by 
omental adipocytes, further studies will be needed to 
identify factors controlling synthesis and release of de-
fensins by peritoneal adipocytes and their contribution to 
the local antibacterial defense mechanism.
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